These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14612937)

  • 1. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma.
    Kaicker S; McCrudden KW; Beck L; New T; Huang J; Frischer JS; Serur A; Kadenhe-Chiweshe A; Yokoi A; Kandel JJ; Yamashiro DJ
    Int J Oncol; 2003 Dec; 23(6):1651-5. PubMed ID: 14612937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
    Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model].
    Zhai Y; Lu ZJ
    Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
    Keyes KA; Mann L; Sherman M; Galbreath E; Schirtzinger L; Ballard D; Chen YF; Iversen P; Teicher BA
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):133-40. PubMed ID: 14593497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
    Frischer JS; Huang J; Serur A; Kadenhe-Chiweshe A; McCrudden KW; O'Toole K; Holash J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
    Int J Oncol; 2004 Sep; 25(3):549-53. PubMed ID: 15289855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor.
    Kim E; Moore J; Huang J; Soffer S; Manley CA; O'Toole K; Middlesworth W; Stolar CJ; Kandel JJ; Yamashiro DJ
    J Pediatr Surg; 2001 Feb; 36(2):287-90. PubMed ID: 11172417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thalidomide on colorectal cancer liver metastases in CBA mice.
    Daruwalla J; Nikfarjam M; Malcontenti-Wilson C; Muralidharan V; Christophi C
    J Surg Oncol; 2005 Aug; 91(2):134-40. PubMed ID: 16028287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
    Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
    Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide attenuates tumor growth and preserves fast-twitch skeletal muscle fibers in cholangiocarcinoma rats.
    Liu KH; Liao LM; Ro LS; Wu YL; Yeh TS
    Surgery; 2008 Mar; 143(3):375-83. PubMed ID: 18291259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic effects and regression of localized murine AML produced by anti-VEGF and anti-Flk-1 antibodies.
    Reichert F; Barak V; Tarshis M; Prindull G; Tarshis E; Ben-Ishay Z
    Eur J Haematol; 2005 Jul; 75(1):41-6. PubMed ID: 15946309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effect of thalidomide and paclitaxel on hepatocellular carcinoma in nude mice.
    Zhang ZL; Liu ZS; Sun Q
    Chin Med J (Engl); 2005 Oct; 118(20):1688-94. PubMed ID: 16313753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
    Du GJ; Lin HH; Xu QT; Wang MW
    Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin.
    Marimpietri D; Nico B; Vacca A; Mangieri D; Catarsi P; Ponzoni M; Ribatti D
    Oncogene; 2005 Oct; 24(45):6785-95. PubMed ID: 16007159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
    Fukasawa M; Korc M
    Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
    Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.
    Soffer SZ; Kim E; Moore JT; Huang J; Yokoi A; Manley C; O'Toole K; Middlesworth W; Stolar C; Yamashiro D; Kandel J
    J Pediatr Surg; 2001 Dec; 36(12):1781-4. PubMed ID: 11733906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.